参考文献/References:
[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. [2]Hiraoka A,Ochi M,Matsuda R,et al.Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitus[J].J Diabetes,2016,8(5):640-646. [3]Ikai I,Arii S,Ichida T,et al.Report of the 16th follow-up survey of primary liver cancer[J]. Hepatology Research,2005,32(3):163-172. [4]Ikai I,Arii S,Okazaki M,et al.Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan[J].Hepatology Research,2007,37(9):676-691. [5]Kudo M,Izumi N,Ichida T,et al.Report of the 19th follow-up survey of primary liver cancer in Japan[J].Hepatology Research,2016,46(5):372-390. [6]Hiraoka A,Kumada T,Tsuji K,et al.Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients:A Multicenter Analysis[J].Liver Cancer,2019,8(2):121-129. [7]Hiraoka A,Michitaka K,Kumada T,et al.ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma:Advantage of ALBI Grade for Universal Assessment of Hepatic Function[J].Liver Cancer,2017,6(4):377-379. [8]Na SK,Yim SY,Suh SJ,et al.ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma[J].J Surg Oncol,2018,117(5):912-921. [9]Johnson PJ,Berhane S,Kagebayashi C,et al.Assessment of liver function in patients with hepatocellular carcinoma:a new evidence-based approach-the ALBI grade[J].Journal of Clinical Oncology,2015,33(6):550-558. [10]Luo HM,Zhao SZ,Li C,et al.Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis Bvirus-related hepatocellular carcinoma after liver resection:A retrospective study[J].Medicine,2018,97(12):e0226. [11]Zhao S,Wang M,Yang Z,et al.Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC[J]. Ann Transl Med,2020,8(8):539. [12]Wang YY,Zhong JH,Su ZY,et al.Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma[J].Br J Surg,2016,103(6):725-734. [13]Geng L,Zong R,Shi Y,et al.Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection:a systematic review and meta-analysis[J].Eur J Gastroenterol Hepatol,2020,32(7):769-778. [14]Amisaki M,Uchinaka E,Morimoto M,et al.Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection[J].Hepatobiliary Pancreat Dis Int,2018,17(6):502-509. [15]Cho WR,Hung CH,Chen CH,et al.Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery[J].Sci Rep,2020,10(1):7290. [16]Li C,Zhang XY,Peng W,et al.Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria[J].World J Surg,2018,42(6):1841-1847. [17]Lin CY,Lin CC,Wang CC,et al.The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection[J].World J Surg,2020,44(1): 247-257. [18]中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范(2019年版)[J].中国临床医学,2020,27(1):140-160. [19]Zhang W,Liu C,Tan Y,et al.Albumin-Bilirubin Score for Predicting Post-Transplant Complications Following Adult-to-Adult Living Donor Liver Transplantation[J].Ann Transplant,2018(23):639-646. [20]Bernardi N,Chedid MF,Grezzana-Filho TJM,et al.Pre-transplant ALBI Grade 3 Is Associated with Increased Mortality After Liver Transplantation[J].Dig Dis Sci,2019,64(6):1695-1704. [21]Kornberg A,Witt U,Schernhammer M,et al.The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma[J].J Surg Oncol,2019,120(7):1126-1136. [22]Tai K,Kuramitsu K,Kido M,et al.Impact of Albumin-Bilirubin Score on Short-and Long-Term Survival After Living-Donor Liver Transplantation:A Retrospective Study[J].Transplant Proc,2020,52(3):910-919. [23][Diagnosis,management,and treatment of hepatocellular carcinoma(V2017)][J].Chinese Journal of Hepatology,2017,25(12):886-895. [24]Kao WY,Su CW,Chiou YY,et al.Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation[J].Radiology,2017,285(2):670-680. [25]Ho SY,Liu PH,Hsu CY,et al.Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation[J].Sci Rep,2018,8(1):843. [26]Kim JH,Sinn DH,Lee JH,et al.Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization[J].Dig Dis Sci,2018,63(4):1062-1071. [27]Waked I,Berhane S,Toyoda H,et al.Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion[J].Br J Cancer,2017,116(4):448-454. [28]Zhao S,Zhang T,Li H,et al.Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC[J].Ann Transl Med,2020,8(8):538. [29]谢雪焜,王宗玉,陈欣欣,等.4种评分系统预测肝细胞癌患者经肝动脉化疗栓塞术后肝衰竭的价值[J]. 中国肿瘤临床,2020,47(12):614-620. [30]Huang Z,Zuo M,Ni J,et al.Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma(Diameter＞4cm)Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin grade:A Preliminary Study[J].Cancer Manag Res,2020(12):1373-1385. [31]Lo CH,Liu MY,Lee MS,et al.Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy[J].International Journal of Radiation Oncology,Biology,Physics,2017,99(1):145-152. [32]Jeliazkova P,Umgelter A,Braren R,et al.Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization:a retrospective study[J].Eur J Gastroenterol Hepatol,2020,32(8):1036-1041. [33]Mohammadi H,Abuodeh Y,Jin W,et al.Using the Albumin-Bilirubin(ALBI)grade as a prognostic marker for radioembolization of hepatocellular carcinoma[J].Journal of Gastrointestinal Oncology,2018,9(5):840-846. [34]Gui B,Weiner AA,Nosher J,et al.Assessment of the Albumin-Bilirubin(ALBI)Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization[J].Am J Clin Oncol,2018,41(9):861-866. [35]Antkowiak M,Gabr A,Das A,et al.Prognostic Role of Albumin,Bilirubin,and ALBI Scores:Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization[J].Cancers(Basel),2019,11(6):879. [36]Su TS,Yang HM,Zhou Y,et al.Albumin - bilirubin(ALBI)versus Child-Turcotte-Pugh(CTP)in prognosis of HCC after stereotactic body radiation therapy[J].Radiat Oncol,2019,14(1):50. [37]Kuo YH,Wang JH,Hung CH,et al.Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use[J].J Gastroenterol Hepatol,2017,32(12):1975-1981. [38]Pinato DJ,Kaneko T,Saeed A,et al.Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade[J].Cancers(Basel),2020,12(7). [39]Rovesti G,Orsi G,Kalliopi A,et al.Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib:Ten Years of Experience[J].Gastrointest Tumors,2019,6(3-4):92-107. [40]Yukimoto A,Hirooka M,Hiraoka A,et al.Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma[J].Jpn J Clin Oncol,2019,49(1):42-47. [41]Hiraoka A,Kumada T,Atsukawa M,et al.Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma[J].Oncology,2019,97(5):277-285. [42]Harimoto N,Yoshizumi T,Sakata K,et al.Prognostic significance of combined albumin-bilirubin and tumor-node-metastasis staging system in patients who underwent hepatic resection for hepatocellular carcinoma[J].Hepatol Res,2017,47(12):1289-1298. [43]Li C,Zhang XY,Peng W,et al.Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection[J].Medicine(Baltimore),2018,97(29):e11599. [44]Liu PH,Hsu CY,Hsia CY,et al.ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era[J].J Gastroenterol Hepatol,2017,32(4):879-886. [45]刘朔珲,严俊,张奇煜,等.白蛋白-胆红素评分联合标准化残肝体积比对肝细胞癌患者肝切除术后肝功能衰竭的预测价值[J].中国普外基础与临床杂志,2019,26(5):545-550. [46]Lee PC,Chen YT,Chao Y,et al.Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma[J].Liver Int,2018,38(2):321-330. [47]Liao R,Jiang N,Tang ZW,et al.Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery[J].Oncotarget,2016,7(21):30951-30961. [48]Ho SY,Liu PH,Hsu CY,et al.A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria[J].Dig Dis Sci,2020,65(2):658-667.
相似文献/References:
[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Medical Information,2018,31(08):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Medical Information,2018,31(08):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Medical Information,2019,32(08):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Medical Information,2018,31(08):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[5]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Medical Information,2018,31(08):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[6]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的
相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Medical Information,2019,32(08):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[7]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Medical Information,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[8]孙 逊.性化护理对肝癌患者CT引导下射频消融术后
负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after
CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Medical Information,2019,32(08):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[9]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Medical Information,2019,32(08):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[10]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Medical Information,2019,32(08):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]